Mill Medical Technology

The company develops and manufactures laser medical equipment for various clinical departments, including dentistry, dermatology, urology, and vascular surgery. Its technology is designed for multiple treatment scenarios such as soft tissue cutting, hard tissue ablation, lithotripsy (stone breaking), and anti-aging treatments. One of its key product lines is the Thulium fiber laser medical device, which utilizes the 1940nm wavelength for more precise and minimally invasive procedures. In 2024, the company's self-developed Thulium fiber laser treatment system received NMPA Class III medical device registration in China, marking a significant step in the domestic production of high-end oral laser medical equipment.

Mill Medical has secured significant funding to support its growth. A Series B funding round in June 2026, led by Shenzhen Capital Group (SCGC), raised approximately 100 million RMB. This capital is intended for the clinical registration and commercialization of its devices, continued R&D of core laser technologies, and expansion of its global market channels. Previous funding includes a Pre-A round in November 2021 and an A round in August 2024. The company's business strategy involves a dual approach of establishing its brand in high-end hospitals while also providing cost-effective models for primary care and private medical markets. Mill Medical holds over 200 intellectual property rights and has developed nearly 30 different lasers for various medical applications.